Internformat: Renal Cell Carcinoma

Renal Cell Carcinoma

1. Verfasser:	López, José I. , [VerfasserIn]
Umfang/Format:	1 online resource (500 pages).
Schlagworte:	N-glycomapping n/a SMAD proteins patient survival pro-IL-1? survival prediction inflammation markers tumor migration prognostic factors practical approach circular RNAs in a clinico-genomic predictive model glycomarkers review nephrectomy uric acid VEGF inhibitors metabolic reprogramming collecting duct carcinoma curcumin metabolome profiling identification of circular RNAs IL-2 experimental validation of circular RNA Raf/MEK/ERK HOT PI3K/Akt/mTOR pentose phosphate pathway kidney cancer LOT mutation RCC polybromo-1 pale cell MMP-9 gene expression recurrence free survival chromosomal loss IL-1? chronic kidney disease glutathione transferase omega 2 label-free glutathione transferase omega 1 emerging entity copy number alteration FOXO3 predictive role tumor slice culture tyrosine kinase inhibitors PPP ESC CDKN1A expression metastasis PD-L1 diagnostic and prognostic markers EVI1 copy number loss RNA sequencing NK cells glutathione metabolism clear cell renal cell carcinoma renal cell cancer proliferation eosinophilic variant Xp11 translocation renal cell carcinoma prognosis invasion immune infiltration IL4R? FISH 11) translocation renal cell carcinoma tumor microenvironment metabolome hyperosmolality toxicity ALK drug sensitivity t(6 copy number analysis urine genetic association polymorphism solute carrier proteins kidney metastatic ccRCC molecular genetic features recurrence-free survival chromophobe renal cell carcinoma unclassified renal tumor overall survival mTOR inhibitors mTOR JAK2 von Hippel-Lindau miR-155-5p glycoproteomics PBRM1 miR-133b survival TFE3 TFEB oncocytic renal tumor immune checkpoint inhibitors biomarker MMP10 TCGA ghrelin EMT like checkpoint inhibitors MiT family translocation renal cell carcinoma gene signature sarcomatoid transforming growth factor beta clear cell Renal Cell Carcinoma tumor adhesion renal cancer unclassified renal cell carcinoma Papillary renal cell carcinoma (pRCC) miR-146a-5p renal cell everolimus integrins cytoreductive nephrectomy immunotherapy predictive factors immunohistochemistry MTA2 IL13R?1 targeted therapy intratumour heterogeneity aurora A TCA cycle AMP-activated protein kinases cancer-specific survival programmed death-ligand 1 efficacy renal cell carcinoma anaplastic lymphoma kinase rearrangement TFEB-amplified renal cell carcinoma statins cancer immunotherapy microRNA new entity proteome profiling
Online Zugang:	DOAB: download the publication DOAB: description of the publication


LEADER	06165namaa2202113ui 4500
001	003028474
005	20221228154511.0
003	DE-2553
006	m o d
007	cr\|mn\|---annan
008	20210212s2020 xx \|\|\|\|\|o \|\|\| 0\|eng d
020			\|a books978-3-03928-639-3
020			\|a 9783039286386
020			\|a 9783039286393
040			\|a oapen \|c oapen \|b eng \|d DE-2553 \|e rda
024	7		\|a 10.3390/books978-3-03928-639-3 \|c doi
041	0		\|a eng
042			\|a dc
100	1		\|a López, José I. \|e author
245	1	0	\|a Renal Cell Carcinoma
264			\|b MDPI - Multidisciplinary Digital Publishing Institute, \|c 2020.
300			\|a 1 online resource (500 pages).
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
506	0		\|a Open Access \|2 star \|f Unrestricted online access
540			\|a Creative Commons \|f https://creativecommons.org/licenses/by-nc-nd/4.0/ \|2 cc \|4 https://creativecommons.org/licenses/by-nc-nd/4.0/
546			\|a English
653			\|a N-glycomapping
653			\|a n/a
653			\|a SMAD proteins
653			\|a patient survival
653			\|a pro-IL-1?
653			\|a survival prediction
653			\|a inflammation markers
653			\|a tumor migration
653			\|a prognostic factors
653			\|a practical approach
653			\|a circular RNAs in a clinico-genomic predictive model
653			\|a glycomarkers
653			\|a review
653			\|a nephrectomy
653			\|a uric acid
653			\|a VEGF inhibitors
653			\|a metabolic reprogramming
653			\|a collecting duct carcinoma
653			\|a curcumin
653			\|a metabolome profiling
653			\|a identification of circular RNAs
653			\|a IL-2
653			\|a experimental validation of circular RNA
653			\|a Raf/MEK/ERK
653			\|a HOT
653			\|a PI3K/Akt/mTOR
653			\|a pentose phosphate pathway
653			\|a kidney cancer
653			\|a LOT
653			\|a mutation
653			\|a RCC
653			\|a polybromo-1
653			\|a pale cell
653			\|a MMP-9
653			\|a gene expression
653			\|a recurrence free survival
653			\|a chromosomal loss
653			\|a IL-1?
653			\|a chronic kidney disease
653			\|a glutathione transferase omega 2
653			\|a label-free
653			\|a glutathione transferase omega 1
653			\|a emerging entity
653			\|a copy number alteration
653			\|a FOXO3
653			\|a predictive role
653			\|a tumor slice culture
653			\|a tyrosine kinase inhibitors
653			\|a PPP
653			\|a ESC
653			\|a CDKN1A expression
653			\|a metastasis
653			\|a PD-L1
653			\|a diagnostic and prognostic markers
653			\|a EVI1
653			\|a copy number loss
653			\|a RNA sequencing
653			\|a NK cells
653			\|a glutathione metabolism
653			\|a clear cell renal cell carcinoma
653			\|a renal cell cancer
653			\|a proliferation
653			\|a eosinophilic variant
653			\|a Xp11 translocation renal cell carcinoma
653			\|a prognosis
653			\|a invasion
653			\|a immune infiltration
653			\|a IL4R?
653			\|a FISH
653			\|a 11) translocation renal cell carcinoma
653			\|a tumor microenvironment
653			\|a metabolome
653			\|a hyperosmolality
653			\|a toxicity
653			\|a ALK
653			\|a drug sensitivity
653			\|a t(6
653			\|a copy number analysis
653			\|a urine
653			\|a genetic association
653			\|a polymorphism
653			\|a solute carrier proteins
653			\|a kidney
653			\|a metastatic ccRCC
653			\|a molecular genetic features
653			\|a recurrence-free survival
653			\|a chromophobe renal cell carcinoma
653			\|a unclassified renal tumor
653			\|a overall survival
653			\|a mTOR inhibitors
653			\|a mTOR
653			\|a JAK2
653			\|a von Hippel-Lindau
653			\|a miR-155-5p
653			\|a glycoproteomics
653			\|a PBRM1
653			\|a miR-133b
653			\|a survival
653			\|a TFE3
653			\|a TFEB
653			\|a oncocytic renal tumor
653			\|a immune checkpoint inhibitors
653			\|a biomarker
653			\|a MMP10
653			\|a TCGA
653			\|a ghrelin
653			\|a EMT like
653			\|a checkpoint inhibitors
653			\|a MiT family translocation renal cell carcinoma
653			\|a gene signature
653			\|a sarcomatoid
653			\|a transforming growth factor beta
653			\|a clear cell Renal Cell Carcinoma
653			\|a tumor adhesion
653			\|a renal cancer
653			\|a unclassified renal cell carcinoma
653			\|a Papillary renal cell carcinoma (pRCC)
653			\|a miR-146a-5p
653			\|a renal cell
653			\|a everolimus
653			\|a integrins
653			\|a cytoreductive nephrectomy
653			\|a immunotherapy
653			\|a predictive factors
653			\|a immunohistochemistry
653			\|a MTA2
653			\|a IL13R?1
653			\|a targeted therapy
653			\|a intratumour heterogeneity
653			\|a aurora A
653			\|a TCA cycle
653			\|a AMP-activated protein kinases
653			\|a cancer-specific survival
653			\|a programmed death-ligand 1
653			\|a efficacy
653			\|a renal cell carcinoma
653			\|a anaplastic lymphoma kinase rearrangement
653			\|a TFEB-amplified renal cell carcinoma
653			\|a statins
653			\|a cancer immunotherapy
653			\|a microRNA
653			\|a new entity
653			\|a proteome profiling
856	4	0	\|a www.oapen.org \|u https://mdpi.com/books/pdfview/book/2229 \|7 0 \|z DOAB: download the publication
856	4	0	\|a www.oapen.org \|u https://directory.doabooks.org/handle/20.500.12854/58186 \|7 0 \|z DOAB: description of the publication
590			\|a Online publication
590			\|a ebookoa1222
590			\|a doab
942			\|2 z \|c EB
999			\|c 3028474 \|d 1432229
952			\|0 0 \|1 0 \|2 z \|4 0 \|6 ONLINE \|7 1 \|9 974113 \|R 2022-12-28 14:45:11 \|a DAIG \|b DAIG \|l 0 \|o Online \|r 2022-12-28 \|y EB

Renal Cell Carcinoma

Ähnliche Einträge